India's top tuberculosis fighter said the government will expand access to Johnson & Johnson's breakthrough TB drug this year, but health experts warn much more needs to be done to eliminate the superbug by 2025. India will make bedaquiline, one of just two new TB drugs marketed over the last 50 years, available at 140 government-run TB treatment centres by November, said Sunil Kharpade, head of India's Central TB Division. The drug is currently available at only six centres.